“…The diagnostic and prognostic utilities of these ratios have been observed in several inflammation-related diseases, including cancer, type 2 diabetes mellitus (T2DM), diabetic kidney injury, nonalcoholic fatty liver disease, inflammatory bowel disease, epilepsy, Guillain-Barré syndrome, and COVID-2019 [ 9 , 11 – 17 ]. Furthermore, according to recent studies, these parameters are predictive markers for the development of poststroke complications, including early neurological deterioration and poststroke depression [ 5 , 18 ]. Moreover, from a practical point of view, a complete blood count analysis is one of the quickest, simplest, most accessible, and most economical laboratory tests.…”